title: Optical imaging in breast cancer diagnosis: the next evolution.
abstract: Breast cancer is one of the most common cancers among the population of the Western world. Diagnostic methods include mammography, ultrasound, and magnetic resonance; meanwhile, nuclear medicine techniques have a secondary role, being useful in regional assessment and therapy followup. Optical imaging is a very promising imaging technique that uses near-infrared light to assess optical properties of tissues and is expected to play an important role in breast cancer detection. Optical breast imaging can be performed by intrinsic breast tissue contrast alone (hemoglobin, water, and lipid content) or with the use of exogenous fluorescent probes that target specific molecules for breast cancer. Major advantages of optical imaging are that it does not use any radioactive components, very high sensitivity, relatively inexpensive, easily accessible, and the potential to be combined in a multimodal approach with other technologies such as mammography, ultrasound, MRI, and positron emission tomography. Moreover, optical imaging agents could, potentially, be used as "theranostics," combining the process of diagnosis and therapy.
authors.affiliation: Molecular Imaging Program, PET Radiopharmacy Unit, Molecular Imaging Group, IDIS, GALARIA-SERGAS, University Hospital Complex, Travesía de Choupana s/n., 15706 Santiago de Compostela, Spain.
authors.forename: Michel
authors.initials: M
authors.lastname: Herranz
authors.forename: Alvaro
authors.initials: A
authors.lastname: Ruibal